Browse studies

Find your next paid study

26,866 recruiting studies available now

Magnetic Resonance Imaging (MRI) Derived Quantitative Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy

Doctors leading this study hope to learn about a software that researchers at the University of Chicago have developed to help analyze radiographic images (dif…

Prostate CancerProstate AdenocarcinomaProstate Neoplasm

Estimated

~$10 – $6,250

University of ChicagoNCT05710380

Regional Cerebral Blood Flow Studies of Object Perception, Identification, Localization, and Memory

The purpose of this study is to use brain imaging technology to measure changes in blood flow to areas in the brain as individuals perform intellectual tasks. …

Healthy Volunteer

Estimated

~$10 – $675

National Institute of Mental Health (NIMH)NCT00001360

Fasting Hypoglycemia: Diagnosis and Treatment

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia. Patients i…

HypoglycemiaInsulinoma

Estimated

~$10 – $675

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT00001276

Observational

Hot, Cold, and Combined Thermodynamic Exposure to Improve Sleep Quality Among Military Cadets

This pilot study investigates the effects of cold-water immersion, traditional sauna use, and their combination on sleep architecture and psychological health …

Cold-water ImmersionHigh Heat SaunaCombination of Cold-water Immersion and High Heat Sauna

Estimated

~$10 – $6,250

Medical University of South CarolinaNCT07201935

Phase 2

A Phase 2a, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of a THRβ Agonist (ECC4703), an SSAO Inhibitor (ECC0509), and Their Combination in Adults With Presumed MASH

The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and …

Metabolic Dysfunction-associated Steatohepatitis

A Phase 2, Multicenter, Open-label, Randomized, Controlled Study of LX2006 Gene Therapy in Participants With Friedreich Ataxia Cardiomyopathy (SUNRISE-FA 2)

The purpose of Study LX2006-03, a multicenter, Phase 2, open-label, randomized, controlled study, is to evaluate the efficacy and safety of LX2006 gene therapy…

Friedreich AtaxiaCardiomyopathy, Secondary

Estimated

~$10 – $8,750

Lexeo TherapeuticsNCT07721025

Long-Term Follow-UP of Survivors of Pediatric Cushing Disease

Background: The pituitary gland produces hormones. A tumor in this gland can cause it to produce too much of the hormone cortisol. Too much cortisol in the bo…

Cushing Disease

Estimated

~$10 – $675

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT03831958

Phase 3

A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice (TPC) in Participants With Triple-Negative Breast Cancer (TNBC) Who Received Neoadjuvant Therapy and Did Not Achieve a Pathological Complete Response (pCR) at Surgery

This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compar…

Triple-Negative Breast Cancer

Estimated

~$10 – $8,750

Merck Sharp & Dohme LLCNCT06393374

Phase 1

An Open-Label, Multicenter, Phase 1/2 Dose-Escalation and Expansion Trial Evaluating the Safety and Efficacy of FT839 in Participants With Autoimmune Diseases

The primary objectives of this trial are to evaluate the safety and tolerability and to determine the maximum tolerated dose (MTD) or recommended Phase 2 dose …

ANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)+2 more

Estimated

~$10 – $8,750

Fate TherapeuticsNCT07800871

Observational

Pilot Trial Evaluating a Mechanical Power Targeted Ventilation Strategy in Adult VV ECMO Patients With Severe ARDS

The purpose of this study is to find a better way to protect the lungs of patients with Acute Respiratory Distress Syndrome (ARDS) who are being treated with a…

ARDS (Acute Respiratory Distress Syndrome)VV ECMO

Estimated

~$10 – $6,250

University of VirginiaNCT07790133

Phase 1

A Phase I/II, Open-label, Adaptive Two-part Trial to Evaluate the Safety, Efficacy, Optimal Dose and Pharmacokinetics of BNT326 as Monotherapy and in Combination With Cancer Immunotherapies in Participants With Advanced Solid Tumors

This study will evaluate the safety, efficacy, optimal dose, and pharmacokinetics (PK) of BNT326 as monotherapy (Part 1) and as combination treatment with immu…

Advanced Solid Tumor

Estimated

~$10 – $7,500

BioNTech SENCT07070232

Phase 3

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Felzartamab in Adults With IgA Nephropathy (PREVAIL)

In this study, researchers will learn more about the use of felzartamab in participants with immunoglobulin A nephropathy (IgAN). IgAN is a kidney disease caus…

Immunoglobulin A Nephropathy (IgAN)

Estimated

~$10 – $7,500

BiogenNCT06935357